Skip to content

Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry: a Pilot Study

Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01483495
Acronym
DOSI
Enrollment
78
Registered
2011-12-01
Start date
2011-12-31
Completion date
2011-12-31
Last updated
2022-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxia-Ischemia, Brain, Signs and Symptoms

Brief summary

The brain is such a metabolically active organ that it consumes about 20% of oxygen burned every minute by an average adult even though it only contributes about 2% of the body weight. As a result, the brain produces a disproportionately high amount of CO2 every minute in comparison with the rest of the body.

Detailed description

The researcher can use Diffuse Optical Spectroscopy Imaging, cerebral non-invasive oximetry instrument, to determine cerebrovascular reactivity during surgery procedure. Specifically, the cerebral tissue O2 saturation can measure by Diffuse Optical Spectroscopy Imaging can use for cerebral blood flow in the evaluation of cerebrovascular reactivity. Adequate brain perfusion is critical not only to supply oxygen and nutrients but also to wash out metabolic end products including CO2. Blood flow depends on perfusion pressure and vascular bed resistance. It is well known that multiple physiological and pathological factors affect cerebral vasculature, and the resistance to blood flow. The cerebrovascular responsiveness to those factors determines how well the brain can maintain and adjust its perfusion.

Interventions

Diffuse Optical Spectroscopy Imaging Cerebrovascular Reactivity

Sponsors

Beckman Laser Institute University of California Irvine
CollaboratorOTHER
University of California, Irvine
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male or Female 20 years of age and older 2. Female non-pregnant 3. Subject scheduled for elective surgery under general anesthesia with intubation. 4. Subject who is able to give informed consent.

Exclusion criteria

1. Less than 20 years old of age 2. Pregnant woman 3. Subjects currently diagnosed with severe hypertension, myocardial ischemic disease, symptomatic valvular disease(s), symptomatic arrhythmia, uncompensated congestive heart failure, intracranial aneurysm.

Design outcomes

Primary

MeasureTime frameDescription
Brain blood flow6 hoursOptical Imaging assess of Brain blood flow during surgical procedure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026